Trial Profile
A trial to assess the effects of tocilizumab, versus infliximab, on cervical lesions in Japanese patients with active rheumatoid arthritis, who were listed in the Tsurumai Biologics Communication Registry
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Aug 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary) ; Infliximab
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics; Therapeutic Use
- 08 Aug 2015 New trial record
- 10 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.